Paul Hiss, MD
Ophthalmology · Sparks, NVNPI 1578522256
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $7,039 of the $9,475 with a category attached, or 74.3%. 16 manufacturers reported payments, led by Heru, Inc. at 56.1% of the total. Reporting peaked in 2022 at $5,662 and has fallen 67.7% since, to $1,831 in 2025.
Across 77 payments — averaging $123.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Heru, Inc.$5K
- Rxsight Inc$2K
- Alcon$1K
- Biotissue Holdings Inc.$231
- Johnson & Johnson Surgical Vision, Inc.$148
- Kala Pharmaceuticals, Inc.$147
- plus $719 from 10 others
What the payments were for
- Consulting fees$7,03974%
- Speaking & faculty fees$320%
- Food & beverage$2,36525%
- Gifts$390%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Heru, Inc. | 1 | $5,316 |
| Rxsight Inc | 7 | $1,827 |
| Alcon | 21 | $1,087 |
| Biotissue Holdings Inc. | 8 | $231 |
| Johnson & Johnson Surgical Vision, Inc. | 7 | $148 |
| Kala Pharmaceuticals, Inc. | 17 | $147 |
| Tarsus Pharmaceuticals, Inc. | 2 | $128 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $127 |
| AbbVie | 3 | $117 |
| Eyevance Pharmaceuticals LLC | 1 | $105 |
| Carl Zeiss Meditec, Inc. | 1 | $82 |
| Bausch & Lomb Americas Inc. | 3 | $53 |
| Carl Zeiss Meditec AG | 2 | $39 |
| Sun Pharmaceutical Industries Inc. | 1 | $32 |
| Novartis | 1 | $19 |
| Sight Sciences, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Heru HMD$5,316
- RXSIGHT CONTACT LENS$1,723
- RXSIGHT INJECTOR CARTRIDGE$1,723
- LIGHT ADJUSTABLE LENS (LAL)$1,723
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$1,723
- RXSIGHT INJECTOR HANDPIECE$1,723
- Clareon$406
- ENVISTA$127
- STELLARIS$127
- Centurion$112
- XDEMVY$108
- Zerviate$105
How this compares
$9,475 in reported general payments places this provider in the 80th percentile of 121 ophthalmology providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XiidraLifitegrast | 13 | $12,676 |
| Prednisolone Acetate | 99 | $4,802 |
| Ofloxacin | 96 | $1,448 |
| Ketorolac Tromethamine | 26 | $533 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Bausch & Lomb Americas Inc.Xiidra | $53 | $12,67613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 121 ophthalmology providers in Nevada.
Other ophthalmology in Sparks
- Curtis ManningSparks$74K
- Arshad KhananiReno$2M
- Eva LiangLas Vegas$496K
- Rene ZamoraHenderson$216K
- Steven LeibowitzLas Vegas$147K
- Steve ChangReno$75K
- Wonchon LinLas Vegas$43K
- Darrick NeibaurHenderson$36K
- Ravindranath ReddyLas Vegas$30K
- Emily SchorrLas Vegas$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.